| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBIO | Common Stock | Options Exercise | +30.5K | +8.93% | 372K | Nov 16, 2022 | Direct | F1, F2 | ||
| transaction | BBIO | Common Stock | Tax liability | -$104K | -10.8K | -2.9% | $9.64 | 361K | Nov 16, 2022 | Direct | F3 |
| transaction | BBIO | Common Stock | Sale | -$185K | -19.7K | -5.45% | $9.40 | 341K | Nov 17, 2022 | Direct | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBIO | Restricted Stock Units | Options Exercise | $0 | -1.71K | -14.29% | $0.00 | 10.3K | Nov 16, 2022 | Common Stock | 1.71K | Direct | F1, F5 | |
| transaction | BBIO | Restricted Stock Units | Options Exercise | $0 | -778 | -10% | $0.00 | 7K | Nov 16, 2022 | Common Stock | 778 | Direct | F1, F6 | |
| transaction | BBIO | Restricted Stock Units | Options Exercise | $0 | -24.2K | -16.67% | $0.00 | 121K | Nov 16, 2022 | Common Stock | 24.2K | Direct | F1, F7 | |
| transaction | BBIO | Restricted Stock Units | Options Exercise | $0 | -3.79K | -25% | $0.00 | 11.4K | Nov 16, 2022 | Common Stock | 3.79K | Direct | F1, F8 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| F2 | Includes 4 shares acquired by the Reporting Person on August 15, 2022 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
| F3 | Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 30,467 shares of Common Stock underlying the Reporting Person's RSUs. |
| F4 | Represents the weighted average sale price of the shares sold from $9.14 to $9.64 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein. |
| F5 | The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. |
| F6 | The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date. |
| F7 | The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |
| F8 | The RSUs will vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. |